Particle Morphology as a Critical Material Attribute in Pharmaceutical Development: Characterization, Quality Impact, and Control Strategies — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Particle Morphology as a Critical Material Attribute in Pharmaceutical Development: Characterization, Quality Impact, and Control Strategies
Particle morphology plays a key role in the physical, chemical, and processing properties of active pharmaceutical ingredients (APIs) and excipients. This review examines how particle size, shape, surface texture, and crystallinity influence pharmaceutical development and manufacturing. It outlines the main characterization methods, including scanning electron microscopy (SEM), transmission electron microscopy (TEM), atomic force microscopy (AFM), laser diffraction, dynamic light scattering (DLS), and Raman chemical imaging. The review also covers how particle morphology influences drug properties like dissolution rate, bioavailability, powder flow, compressibility, content uniformity, and aerodynamic behavior. Both top-down methods, such as milling and homogenization, and bottom-up methods, such as crystallization and spray drying, are discussed within the Quality by Design (QbD) framework. Regulatory guidelines from the International Council for Harmonization (ICH) and pharmacopeial standards are included. The article examines the role of particle shape in drug delivery for oral, pulmonary, and parenteral routes. Although there have been many advances, challenges remain in achieving reliable three-dimensional characterization, scaling up engineering methods, and creating standardized shape descriptors. This review aims to serve as a useful resource for scientists, formulators, and regulatory professionals seeking to leverage particle morphology to improve drug quality and performance. In summary, research shows that particle morphology is an important material attribute in pharmaceutical development. It needs careful, risk-based characterization, clear, science-based specifications, and integrated control strategies throughout the product’s lifecycle.
KeywordsParticle MorphologyParticle Size Distribution (PSD)Crystal EngineeringPharmaceutical CharacterizationScanning Electron Microscopy (SEM)Dissolution RateBioavailabilityQuality by Design (QBD)
Burgess, D.J., Duffy, E., Etzler, F. and Hickey, A.J. (2004) Particle Size Analysis: AAPS Workshop Report, Cosponsored by the Food and Drug Administration and the United States Pharmacopeia. The AAPS Journal , 6, 23-34. https://doi.org/10.1208/aapsj060320
Morrison, H., Osan, R., Horstman, E., Lee, E., Ritchie, S., Payne, P., et al . (2021) Correlation of Drug Substance Bulk Properties to Predict and Troubleshoot the Formulation of Drug Products: The API Camera. Organic Process Research & Development , 25, 1036-1046. https://doi.org/10.1021/acs.oprd.1c00043
Azad, M.A., Capellades, G., Wang, A.B., Klee, D.M., Hammersmith, G., Rapp, K., et al . (2021) Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations. AAPS PharmSciTech , 22, Article No. 98. https://doi.org/10.1208/s12249-020-01915-6
Rasenack, N. and Müller, B.W. (2002) Crystal Habit and Tableting Behavior. International Journal of Pharmaceutics , 244, 45-57. https://doi.org/10.1016/s0378-5173(02)00296-x
Zhang, S., Stroud, P.A., Zhu, A., Johnson, M.J., Lomeo, J., Burcham, C.L., et al . (2021) Characterizing the Impact of Spray Dried Particle Morphology on Tablet Dissolution Using Quantitative X-Ray Microscopy. European Journal of Pharmaceutical Sciences , 165, Article 105921. https://doi.org/10.1016/j.ejps.2021.105921
Kwon, Y.B., Kang, J.H., Han, C.S., Kim, D.W. and Park, C.W. (2020) The Effect of Particle Size and Surface Roughness of Spray-Dried Bosentan Microparticles on Aerodynamic Performance for Dry Powder Inhalation. Pharmaceutics , 12, Article 765. https://doi.org/10.3390/pharmaceutics12080765
Adi, S., Adi, H., Tang, P., Traini, D., Chan, H. and Young, P.M. (2008) Micro-Particle Corrugation, Adhesion and Inhalation Aerosol Efficiency. European Journal of Pharmaceutical Sciences , 35, 12-18. https://doi.org/10.1016/j.ejps.2008.05.009
Littringer, E.M., Mescher, A., Schroettner, H., Achelis, L., Walzel, P. and Urbanetz, N.A. (2012) Spray Dried Mannitol Carrier Particles with Tailored Surface Properties—The Influence of Carrier Surface Roughness and Shape. European Journal of Pharmaceutics and Biopharmaceutics , 82, 194-204. https://doi.org/10.1016/j.ejpb.2012.05.001
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2009) ICH Q8(R2). Pharmaceutical Development. ICH.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2023) ICH Q9 (R1). Quality Risk Management. ICH.
Critical Quality Attribute (CQA)
Critical Material Attribute (CMA)
Drug Delivery
Powder Flow
ICH Guidelines
Samineni, R., Chimakurthy, J. and Konidala, S. (2022) Emerging Role of Biopharmaceutical Classification and Biopharmaceutical Drug Disposition System in Dosage Form Development: A Systematic Review. Turkish Journal of Pharmaceutical Sciences , 19, 706-713. https://doi.org/10.4274/tjps.galenos.2021.73554
Mirza, S., Miroshnyk, I., Habib, M.J., Brausch, J.F. and Hussain, M.D. (2010) Enhanced Dissolution and Oral Bioavailability of Piroxicam Formulations: Modulating Effect of Phospholipids. Pharmaceutics , 2, 339-350. https://doi.org/10.3390/pharmaceutics2040339
Jinno, J., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., et al . (2006) Effect of Particle Size Reduction on Dissolution and Oral Absorption of a Poorly Water-Soluble Drug, Cilostazol, in Beagle Dogs. Journal of Controlled Release , 111, 56-64. https://doi.org/10.1016/j.jconrel.2005.11.013
Noyes, A.A. and Whitney, W.R. (1897) The Rate of Solution of Solid Substances in Their Own Solutions. Journal of the American Chemical Society , 19, 930-934. https://doi.org/10.1021/ja02086a003
Chan, H.K. (2008) What Is the Role of Particle Morphology in Pharmaceutical Powder Aerosols? Expert Opinion on Drug Delivery , 5, 909-914. https://doi.org/10.1517/17425247.5.8.909
Bergeron, M., Laurin, P. and Tawashi, R. (1986) Effects of Particle Morphology in Selecting Pharmaceutical Excipients. Drug Development and Industrial Pharmacy , 12, 915-926. https://doi.org/10.3109/03639048609048047
Shah, V.P. and Amidon, G.L. (2014) G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability, Pharm Res 12, 413-420, 1995—Backstory of BCS. The AAPS Journal , 16, 894-898. https://doi.org/10.1208/s12248-014-9620-9
Blagden, N., de Matas, M., Gavan, P.T. and York, P. (2007) Crystal Engineering of Active Pharmaceutical Ingredients to Improve Solubility and Dissolution Rates. Advanced Drug Delivery Reviews , 59, 617-630. https://doi.org/10.1016/j.addr.2007.05.011
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (1999) ICH Q6A. Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. ICH.
Erdoğar, N., Akkın, S., Nielsen, T.T., Özçelebi, E., Erdoğdu, B., Nemutlu, E., et al . (2021) Development of Oral Aprepitant-Loaded Chitosan-Polyethylene Glycol-Coated Cyclodextrin Nanocapsules: Formulation, Characterization, and Pharmacokinetic Evaluation. Journal of Pharmaceutical Investigation , 51, 297-310. https://doi.org/10.1007/s40005-020-00511-x
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2008) ICH Q10. Pharmaceutical Quality System. ICH.
Gamble, J.F., Tobyn, M. and Hamey, R. (2015) Application of Image-Based Particle Size and Shape Characterization Systems in the Development of Small Molecule Pharmaceuticals. Journal of Pharmaceutical Sciences , 104, 1563-1574. https://doi.org/10.1002/jps.24382
Hickey, A.J. (2018). Pharmaceutical Powder and Particles. Springer International Publishing.
Swaminathan, V. and Kildsig, D.O. (2000) The Effect of Particle Morphology on the Physical Stability of Pharmaceutical Powder Mixtures: The Effect of Surface Roughness of the Carrier on the Stability of Ordered Mixtures. Drug Development and Industrial Pharmacy , 26, 365-373. https://doi.org/10.1081/ddc-100101242
Pons, M., Vivier, H., Delcour, V., Authelin, J. and Paillères-Hubert, L. (2002) Morphological Analysis of Pharmaceutical Powders. Powder Technology , 128, 276-286. https://doi.org/10.1016/s0032-5910(02)00177-8
Wang, Z., Solomos, M., Axnanda, S., Chen, C., Figus, M., Schenck, L., et al . (2022) Varied Bulk Powder Properties of Micro-Sized API within Size Specifications as a Result of Particle Engineering Methods. Pharmaceutics , 14, Article 1901. https://doi.org/10.3390/pharmaceutics14091901
Allen, T. (1997) Particle Size Measurement: Volume 2: Surface Area and Pore Size Determination. 5th Edition, Chapman & Hall.
Brittain, H.G. (2002) Particle-Size Distribution, Part III: Determination by Analytical Sieving. Pharmaceutical Technology , 26, 56-64.
United States Pharmacopeia (2016) USP General Chapter <429>. Light Diffraction Measurement of Particle Size.
Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., et al . (2018) Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics , 10, Article 57. https://doi.org/10.3390/pharmaceutics10020057
Podczeck, F., Rahman, S.R. and Newton, J.M. (1999) Evaluation of a Standardised Procedure to Assess the Shape of Pellets Using Image Analysis. International Journal of Pharmaceutics , 192, 123-138. https://doi.org/10.1016/s0378-5173(99)00302-6
Qazi, F., Shoaib, M.H., Yousuf, R.I., Nasiri, M.I., Ahmed, K. and Ahmad, M. (2017) Lipids Bearing Extruded-Spheronized Pellets for Extended Release of Poorly Soluble Antiemetic Agent—Meclizine HCL. Lipids in Health and Disease , 16, Article No. 75. https://doi.org/10.1186/s12944-017-0466-x
Almeida-Prieto, S., Blanco-Méndez, J. and Otero-Espinar, F.J. (2007) Microscopic Image Analysis Techniques for the Morphological Characterization of Pharmaceutical Particles: Influence of the Software, and the Factor Algorithms Used in the Shape Factor Estimation. European Journal of Pharmaceutics and Biopharmaceutics , 67, 766-776. https://doi.org/10.1016/j.ejpb.2007.04.001
Bouwman, A.M., Bosma, J.C., Vonk, P., Wesselingh, J.A. and Frijlink, H.W. (2004) Which Shape Factor(s) Best Describe Granules? Powder Technology , 146, 66-72. https://doi.org/10.1016/j.powtec.2004.04.044
Pons, M.N., Vivier, H., Belaroui, K., Bernard-Michel, B., Cordier, F., Oulhana, D., et al . (1999) Particle Morphology: From Visualisation to Measurement. Powder Technology , 103, 44-57. https://doi.org/10.1016/s0032-5910(99)00023-6
Shekunov, B.Y., Chattopadhyay, P., Tong, H.H.Y. and Chow, A.H.L. (2007) Particle Size Analysis in Pharmaceutics: Principles, Methods and Applications. Pharmaceutical Research , 24, 203-227. https://doi.org/10.1007/s11095-006-9146-7
ISO 9276-6 (2008) Representation of Results of Particle Size Analysis—Part 6: Descriptive and Quantitative Representation of Particle Shape and Morphology. https://www.iso.org/standard/39389.html
Babick, F., Mielke, J., Wohlleben, W., Weigel, S. and Hodoroaba, V. (2016) How Reliably Can a Material Be Classified as a Nanomaterial? Available Particle-Sizing Techniques at Work. Journal of Nanoparticle Research , 18, Article No. 158. https://doi.org/10.1007/s11051-016-3461-7
Gross-Rother, J., Blech, M., Preis, E., Bakowsky, U. and Garidel, P. (2020) Particle Detection and Characterization for Biopharmaceutical Applications: Current Principles of Established and Alternative Techniques. Pharmaceutics , 12, Article 1112. https://doi.org/10.3390/pharmaceutics12111112
Mitchell, J., Bauer, R., Lyapustina, S., Tougas, T. and Glaab, V. (2011) Non-Impactor-based Methods for Sizing of Aerosols Emitted from Orally Inhaled and Nasal Drug Products (OINDPs). AAPS PharmSciTech , 12, 965-988. https://doi.org/10.1208/s12249-011-9662-6
Kuriyama, A. and Ozaki, Y. (2014) Assessment of Active Pharmaceutical Ingredient Particle Size in Tablets by Raman Chemical Imaging Validated Using Polystyrene Microsphere Size Standards. AAPS PharmSciTech , 15, 375-387. https://doi.org/10.1208/s12249-013-0064-9
Griffen, J.A., Owen, A.W. and Matousek, P. (2015) Development of Transmission Raman Spectroscopy Towards the in Line, High Throughput and Non-Destructive Quantitative Analysis of Pharmaceutical Solid Oral Dose. The Analyst , 140, 107-112. https://doi.org/10.1039/c4an01798f
Brittain, H.G. (2018) Polymorphism in Pharmaceutical Solids. CRC Press. https://doi.org/10.3109/9781420073225
United States Pharmacopeia (2016) USP General Chapter <776>. Optical Microscopy.
Giannuzzi, L.A. (2018) Scanning Electron Microscopy and X-Ray Microanalysis 4th Edition, Joseph I. Goldstein, Dale E. Newbury, Joseph R. Michael, Nicholas W.M. Ritchie, John Henry J. Scott, David C. Joy, Springer, 2018, 550 pp. ISBN: 978-1-4939-6674-5. Microscopy and Microanalysis , 24, 768-768. https://doi.org/10.1017/s1431927618015271
Bonifazi, G., Barontini, P., Gasbarrone, R., Gattabria, D. and Serranti, S. (2024) Development of a Powder Analysis Procedure Based on Imaging Techniques for Examining Aggregation and Segregation Phenomena. Journal of Imaging , 10, Article 53. https://doi.org/10.3390/jimaging10030053
Williams, D.B. and Carter, C.B. (2009) Transmission Electron Microscopy. Springer US. https://doi.org/10.1007/978-0-387-76501-3
da Silva, R.Y.P., de Menezes, D.L.B., Oliveira, V.D.S., Converti, A. and de Lima, Á.A.N. (2023) Microparticles in the Development and Improvement of Pharmaceutical Formulations: An Analysis of in Vitro and in Vivo Studies. International Journal of Molecular Sciences , 24, Article 5441. https://doi.org/10.3390/ijms24065441
Seidu, T.A., Farooq, M.A., Wande, M.P., Ghayas, S., Kutoka, P.T., Alolga, R.N., et al . (2025) Exploring Drug Repositioning: Enhanced Co-Delivery of Disulfiram and Celecoxib by Nanostructured Lipid Carriers for Breast Cancer Cells. Current Drug Delivery , 22. https://doi.org/10.2174/0115672018287555240426063812
Mota, W.S., Severino, P., Kadian, V., Rao, R., Zielińska, A., Silva, A.M., et al . (2025) Nanometrology: Particle Sizing and Influence on the Toxicological Profile. Frontiers in Nanotechnology , 7, Article 1479464. https://doi.org/10.3389/fnano.2025.1479464
Dapkunas, S.J. and Jillavenkatesa, A. (2001) NIST Recommended Practice Guide: Particle Size Characterization (No. NBS SP 960-1; p. NBS SP 960-1). National Institute of Standards and Technology. https://doi.org/10.6028/NBS.SP.960-1
Khan, I., Saeed, K. and Khan, I. (2019) Nanoparticles: Properties, Applications and Toxicities. Arabian Journal of Chemistry , 12, 908-931. https://doi.org/10.1016/j.arabjc.2017.05.011
Gaiani, C., Burgain, J. and Scher, J. (2013) Surface Composition of Food Powders. In: Handbook of Food Powders , Elsevier, 339-378. https://doi.org/10.1533/9780857098672.2.339
Badin, R., Gaiani, C., Desobry, S., Prakash, S., Bhandari, B. and Burgain, J. (2023) Dynamic Investigation of Maltodextrins Surface Properties by Environmental Atomic Force Microscopy. Food Hydrocolloids , 145, Article 109081. https://doi.org/10.1016/j.foodhyd.2023.109081
Kougoulos, E., Smales, I. and Verrier, H.M. (2011) Towards Integrated Drug Substance and Drug Product Design for an Active Pharmaceutical Ingredient Using Particle Engineering. AAPS PharmSciTech , 12, 287-294. https://doi.org/10.1208/s12249-011-9582-5
Begat, P., Morton, D.A.V., Staniforth, J.N. and Price, R. (2004) The Cohesive-Adhesive Balances in Dry Powder Inhaler Formulations I: Direct Quantification by Atomic Force Microscopy. Pharmaceutical Research , 21, 1591-1597. https://doi.org/10.1023/b:pham.0000041453.24419.8a
Barber, D., Keuter, J. and Kravig, K. (1998) A Logical Stepwise Approach to Laser Diffraction Particle Size Distribution Analysis Methods Development and Validation. Pharmaceutical Development and Technology , 3, 153-161. https://doi.org/10.3109/10837459809028491
ISO 13320 (2020) Particle Size Analysis—Laser Diffraction Methods. https://www.iso.org/standard/69111.html
Kelly, R.N. and Kazanjian, J. (2006) Commerical Reference Shape Standards Use in the Study of Particle Shape Effect on Laser Diffraction Particle Size Analysis. AAPS PharmSciTech , 7, E126-E137. https://doi.org/10.1208/pt070249
Ph.Eur. 2.9.31. Particle Size Analysis by Laser Light Diffraction. European Pharmacopoeia. https://www.semanticscholar.org/paper/2.9.31.-PARTICLE-SIZE-ANALYSIS-BY-LASER-LIGHT/95383d780cfca7904fb7a736bfdf51963e2d58fd
Berne, B.J. and Pecora, R. (2000) Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics. Dover Publications.
Filipe, V., Hawe, A. and Jiskoot, W. (2010) Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by Nanosight for the Measurement of Nanoparticles and Protein Aggregates. Pharmaceutical Research , 27, 796-810. https://doi.org/10.1007/s11095-010-0073-2
Stetefeld, J., McKenna, S.A. and Patel, T.R. (2016) Dynamic Light Scattering: A Practical Guide and Applications in Biomedical Sciences. Biophysical Reviews , 8, 409-427. https://doi.org/10.1007/s12551-016-0218-6
Brittain, H.G. (2003) X-Ray Diffraction of Pharmaceutical Materials. Profiles of Drug Substances , Excipients and Related Methodology , 30, 271-319. https://doi.org/10.1016/S0099-5428(03)30010-3
Campbell Roberts, S.N., Williams, A.C., Grimsey, I.M. and Booth, S.W. (2002) Quantitative Analysis of Mannitol Polymorphs. X-Ray Powder Diffractometry—Exploring Preferred Orientation Effects. Journal of Pharmaceutical and Biomedical Analysis , 28, 1149-1159. https://doi.org/10.1016/s0731-7085(02)00053-5
Morris, K.R., Schlam, R.F., Cao, W. and Short, M.S. (2000) Determination of Average Crystallite Shape by X-Ray Diffraction and Computational Methods. Journal of Pharmaceutical Sciences , 89, 1432-1442. https://doi.org/10.1002/1520-6017(200011)89:11<1432::aid-jps6>3.0.co;2-x
Patterson, A.L. (1939) The Scherrer Formula for X-Ray Particle Size Determination. Physical Review , 56, 978-982. https://doi.org/10.1103/physrev.56.978
Holzwarth, U. and Gibson, N. (2011) The Scherrer Equation versus the ‘Debye-Scherrer Equation’. Nature Nanotechnology , 6, 534. https://doi.org/10.1038/nnano.2011.145
Pritchard, J. and Warman, M. (2011) Physical Morphology and Spectroscopic Classification in the Development of Pharmaceutical Powders. American Pharmaceutical Review , 14. https://www.americanpharmaceuticalreview.com/Featured-Articles/36996-Physical-Morphology-and-Spectroscopic-Classification-in-the-Development-of-Pharmaceutical-Powders/
Farias, G., Shur, J., Price, R., Bielski, E. and Newman, B. (2021) A Systematic Approach in the Development of the Morphologically-Directed Raman Spectroscopy Methodology for Characterizing Nasal Suspension Drug Products. The AAPS Journal , 23, Article No. 73. https://doi.org/10.1208/s12248-021-00605-w
Frosch, T., Wyrwich, E., Yan, D., Popp, J. and Frosch, T. (2019) Fiber-Array-Based Raman Hyperspectral Imaging for Simultaneous, Chemically-Selective Monitoring of Particle Size and Shape of Active Ingredients in Analgesic Tablets. Molecules , 24, Article 4381. https://doi.org/10.3390/molecules24234381
Garg, M. and Rathore, A.S. (2023) Application of PAT in Pharmaceutical Manufacturing: Model-Based Control of Particle Size Distribution in Anti-Solvent Aided Crystallization. Journal of Chemical Technology & Biotechnology , 98, 2806-2811. https://doi.org/10.1002/jctb.7497
Ahmed, B., Brown, C.J., McGlone, T., Bowering, D.L., Sefcik, J. and Florence, A.J. (2019) Engineering of Acetaminophen Particle Attributes Using a Wet Milling Crystallisation Platform. International Journal of Pharmaceutics , 554, 201-211. https://doi.org/10.1016/j.ijpharm.2018.10.073
Muhaimin, M., Chaerunisaa, A.Y. and Bodmeier, R. (2021) Real-Time Particle Size Analysis Using Focused Beam Reflectance Measurement as a Process Analytical Technology Tool for Continuous Microencapsulation Process. Scientific Reports , 11, Article No. 19390. https://doi.org/10.1038/s41598-021-98984-9
Yao, T., Liu, J., Wan, X., Li, B., Rohani, S., Gao, Z., et al . (2023) Deep-Learning Based in Situ Image Monitoring Crystal Polymorph and Size Distribution: Modeling and Validation. AIChE Journal , 70, e18279. https://doi.org/10.1002/aic.18279
Wu, Y., Loper, A., Landis, E., Hettrick, L., Novak, L., Lynn, K., et al . (2004) The Role of Biopharmaceutics in the Development of a Clinical Nanoparticle Formulation of MK-0869: A Beagle Dog Model Predicts Improved Bioavailability and Diminished Food Effect on Absorption in Human. International Journal of Pharmaceutics , 285, 135-146. https://doi.org/10.1016/j.ijpharm.2004.08.001
Alshora, D., Ibrahim, M., Elzayat, E., Almeanazel, O.T. and Alanazi, F. (2019) Defining the Process Parameters Affecting the Fabrication of Rosuvastatin Calcium Nanoparticles by Planetary Ball Mill. International Journal of Nanomedicine , 14, 4625-4636. https://doi.org/10.2147/ijn.s207301
Liu, F. and Shokrollahi, H. (2015) In Vitro Dissolution of Proton-Pump Inhibitor Products Intended for Paediatric and Geriatric Use in Physiological Bicarbonate Buffer. International Journal of Pharmaceutics , 485, 152-159. https://doi.org/10.1016/j.ijpharm.2015.03.008
Thomas, F. (2020) A Great Manipulation: The Value of Engineering Particle Properties. Pharmaceutical Technology , 44, 25-30.
Mirza, S., Miroshnyk, I., Heinämäki, J., Antikainen, O., Rantanen, J., Vuorela, P., et al . (2009) Crystal Morphology Engineering of Pharmaceutical Solids: Tabletting Performance Enhancement. AAPS PharmSciTech , 10, 113-119. https://doi.org/10.1208/s12249-009-9187-4
Champion, J.A., Katare, Y.K. and Mitragotri, S. (2007) Particle Shape: A New Design Parameter for Micro-and Nanoscale Drug Delivery Carriers. Journal of Controlled Release , 121, 3-9. https://doi.org/10.1016/j.jconrel.2007.03.022
Banerjee, A., Qi, J., Gogoi, R., Wong, J. and Mitragotri, S. (2016) Role of Nanoparticle Size, Shape and Surface Chemistry in Oral Drug Delivery. Journal of Controlled Release , 238, 176-185. https://doi.org/10.1016/j.jconrel.2016.07.051
Yildiz, H.M., McKelvey, C.A., Marsac, P.J. and Carrier, R.L. (2015) Size Selectivity of Intestinal Mucus to Diffusing Particulates Is Dependent on Surface Chemistry and Exposure to Lipids. Journal of Drug Targeting , 23, 768-774. https://doi.org/10.3109/1061186x.2015.1086359
Abdulkarim, M., Agulló, N., Cattoz, B., Griffiths, P., Bernkop-Schnürch, A., Borros, S.G., et al . (2015) Nanoparticle Diffusion within Intestinal Mucus: Three-Dimensional Response Analysis Dissecting the Impact of Particle Surface Charge, Size and Heterogeneity across Polyelectrolyte, Pegylated and Viral Particles. European Journal of Pharmaceutics and Biopharmaceutics , 97, 230-238. https://doi.org/10.1016/j.ejpb.2015.01.023
Desai, M.P., Labhasetwar, V., Amidon, G.L. and Levy, R.J. (1996) Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size. Pharmaceutical Research , 13, 1838-1845. https://doi.org/10.1023/a:1016085108889
Bannunah, A.M., Vllasaliu, D., Lord, J. and Stolnik, S. (2014) Mechanisms of Nanoparticle Internalization and Transport across an Intestinal Epithelial Cell Model: Effect of Size and Surface Charge. Molecular Pharmaceutics , 11, 4363-4373. https://doi.org/10.1021/mp500439c
Nekkanti, V., Pillai, R., Venkateshwarlu, V. and Harisudhan, T. (2009) Development and Characterization of Solid Oral Dosage Form Incorporating Candesartan Nanoparticles. Pharmaceutical Development and Technology , 14, 290-298. https://doi.org/10.1080/10837450802585278
Detroja, C. (2011) Enhanced Antihypertensive Activity of Candesartan Cilexetil Nanosuspension: Formulation, Characterization and Pharmacodynamic Study. Scientia Pharmaceutica , 79, 635-651. https://doi.org/10.3797/scipharm.1103-17
Anwar, W., Dawaba, H., Afouna, M., Samy, A., Rashed, M. and Abdelaziz, A. (2020) Enhancing the Oral Bioavailability of Candesartan Cilexetil Loaded Nanostructured Lipid Carriers: In Vitro Characterization and Absorption in Rats after Oral Administration. Pharmaceutics , 12, Article 1047. https://doi.org/10.3390/pharmaceutics12111047
Gwak, H., Choi, J. and Choi, H. (2005) Enhanced Bioavailability of Piroxicam via Salt Formation with Ethanolamines. International Journal of Pharmaceutics , 297, 156-161. https://doi.org/10.1016/j.ijpharm.2005.03.016
Childs, S.L. and Hardcastle, K.I. (2007) Co-crystals of Piroxicam with Carboxylic Acids. Crystal Growth & Design , 7, 1291-1304. https://doi.org/10.1021/cg060742p
Emami, S., Adibkia, K., Barzegar-Jalali, M. and Siahi-Shadbad, M. (2019) Piroxicam Co-crystals with Phenolic Coformers: Preparation, Characterization, and Dissolution Properties. P harmaceutical Development and Technology , 24, 199-210. https://doi.org/10.1080/10837450.2018.1455210
Kakran, M., Shegokar, R., Sahoo, N.G., Al Shaal, L., Li, L. and Müller, R.H. (2012) Fabrication of Quercetin Nanocrystals: Comparison of Different Methods. European Journal of Pharmaceutics and Biopharmaceutics , 80, 113-121. https://doi.org/10.1016/j.ejpb.2011.08.006
Cheshmehnoor, P., Bolourchian, N., Abdollahizad, E., Derakhshi, A., Dadashzadeh, S. and Haeri, A. (2023) Particle Size Tailoring of Quercetin Nanosuspensions by Wet Media Milling Technique: A Study on Processing and Formulation Parameters. Iranian Journal of Pharmaceutical Research , 21, e130626. https://doi.org/10.5812/ijpr-130626
Joshi, G., Kumar, A. and Sawant, K. (2016) Bioavailability Enhancement, Caco-2 Cells Uptake and Intestinal Transport of Orally Administered Lopinavir-Loaded PLGA Nanoparticles. Drug Delivery , 23, 3492-3504. https://doi.org/10.1080/10717544.2016.1199605
Schulze, D. (2007) Powders and Bulk Solids. Springer. https://doi.org/10.1007/978-3-540-73768-1
Freeman, R. (2007) Measuring the Flow Properties of Consolidated, Conditioned and Aerated Powders—A Comparative Study Using a Powder Rheometer and a Rotational Shear Cell. Powder Technology , 174, 25-33. https://doi.org/10.1016/j.powtec.2006.10.016
Carr Jr, R.L. (1965) Evaluating Flow Properties of Solids. Chemical Engineering , 72, 163-168.
Alyami, H., Dahmash, E., Bowen, J. and Mohammed, A.R. (2017) An Investigation into the Effects of Excipient Particle Size, Blending Techniques and Processing Parameters on the Homogeneity and Content Uniformity of a Blend Containing Low-Dose Model Drug. PLOS ONE , 12, e0178772. https://doi.org/10.1371/journal.pone.0178772
Hiestand, E.N. (1997) Mechanical Properties of Compacts and Particles That Control Tableting Success. Journal of Pharmaceutical Sciences , 86, 985-990. https://doi.org/10.1021/js9701061
Mullarney, M.P. and Hancock, B.C. (2006) Mechanical Property Anisotropy of Pharmaceutical Excipient Compacts. International Journal of Pharmaceutics , 314, 9-14. https://doi.org/10.1016/j.ijpharm.2005.12.052
Hinds, W.C. (1999) Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles. 2nd Edition, Wiley.
Crowder, T.M., Rosati, J.A., Schroeter, J.D., Hickey, A.J. and Martonen, T.B. (2002) Fundamental Effects of Particle Morphology on Lung Delivery: Predictions of Stokes’ Law and the Particular Relevance to Dry Powder Inhaler Formulation and Development. Pharmaceutical Research , 19, 239-245. https://doi.org/10.1023/a:1014426530935
Vehring, R. (2008) Pharmaceutical Particle Engineering via Spray Drying. Pharmaceutical Research , 25, 999-1022. https://doi.org/10.1007/s11095-007-9475-1
Loh, Z.H., Samanta, A.K. and Sia Heng, P.W. (2015) Overview of Milling Techniques for Improving the Solubility of Poorly Water-Soluble Drugs. Asian Journal of Pharmaceutical Sciences , 10, 255-274. https://doi.org/10.1016/j.ajps.2014.12.006
Midoux, N., Hošek, P., Pailleres, L. and Authelin, J.R. (1999) Micronization of Pharmaceutical Substances in a Spiral Jet Mill. Powder Technology , 104, 113-120. https://doi.org/10.1016/s0032-5910(99)00052-2
Markarian, J. (2018) Optimizing Particle Engineering Methods for Inhalation Drug Products. Pharmaceutical Technology , 42, 34-38.
Markarian, J. (2013) Using Micronization to Reduce API Particle Size. Pharmaceutical Technology , 11, Article 14.
Keck, C. and Muller, R. (2006) Drug Nanocrystals of Poorly Soluble Drugs Produced by High Pressure Homogenisation. European Journal of Pharmaceutics and Biopharmaceutics , 62, 3-16. https://doi.org/10.1016/j.ejpb.2005.05.009
Müller, R.H., Gohla, S. and Keck, C.M. (2011) State of the Art of Nanocrystals—Special Features, Production, Nanotoxicology Aspects and Intracellular Delivery. European Journal of Pharmaceutics and Biopharmaceutics , 78, 1-9. https://doi.org/10.1016/j.ejpb.2011.01.007
Steenweg, C., Kufner, A.C., Habicht, J. and Wohlgemuth, K. (2021) Towards Continuous Primary Manufacturing Processes—Particle Design through Combined Crystallization and Particle Isolation. Processes , 9, Article 2187. https://doi.org/10.3390/pr9122187
Arpagaus, C. (2018) Pharmaceutical Particle Engineering via Nano Spray Drying—Process Parameters and Application Examples on the Laboratory-Scale. International Journal of Medical Nano Research , 5, 1-15. https://doi.org/10.23937/2378-3664.1410026
Huang, Y. and Dai, W.G. (2014) Fundamental Aspects of Solid Dispersion Technology for Poorly Soluble Drugs. Acta Pharmaceutica Sinica B , 4, 18-25. https://doi.org/10.1016/j.apsb.2013.11.001
Kumar, R., Thakur, A.K., Kali, G., Pitchaiah, K.C., Arya, R.K. and Kulabhi, A. (2023) Particle Preparation of Pharmaceutical Compounds Using Supercritical Antisolvent Process: Current Status and Future Perspectives. Drug Delivery and Translational Research , 13, 946-965. https://doi.org/10.1007/s13346-022-01283-7
Reverchon, E. and De Marco, I. (2006) Supercritical Fluid Extraction and Fractionation of Natural Matter. The Journal of Supercritical Fluids , 38, 146-166. https://doi.org/10.1016/j.supflu.2006.03.020
Rosca, I.D., Watari, F. and Uo, M. (2004) Microparticle Formation and Its Mechanism in Single and Double Emulsion Solvent Evaporation. Journal of Controlled Release , 99, 271-280. https://doi.org/10.1016/j.jconrel.2004.07.007
Nava-Arzaluz, M.G., Piñón-Segundo, E., Ganem-Rondero, A. and Lechuga-Ballesteros, D. (2012) Single Emulsion-Solvent Evaporation Technique and Modifications for the Preparation of Pharmaceutical Polymeric Nanoparticles. Recent Patents on Drug Delivery & Formulation , 6, 209-223. https://doi.org/10.2174/187221112802652633
Iqbal, M., Zafar, N., Fessi, H. and Elaissari, A. (2015) Double Emulsion Solvent Evaporation Techniques Used for Drug Encapsulation. International Journal of Pharmaceutics , 496, 173-190. https://doi.org/10.1016/j.ijpharm.2015.10.057
Shin, J.M., Kim, Y., Yun, H., Yi, G. and Kim, B.J. (2017) Morphological Evolution of Block Copolymer Particles: Effect of Solvent Evaporation Rate on Particle Shape and Morphology. ACS Nano , 11, 2133-2142. https://doi.org/10.1021/acsnano.6b08342
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2023) ICH Q9 (R1). Quality Risk Management. ICH.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2019) ICH Q12. Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management. ICH
Swanepoel, E., Liebenberg, W., de Villiers, M.M. and Dekker, T.G. (2000) Dissolution Properties of Piroxicam Powders and Capsules as a Function of Particle Size and the Agglomeration of Powders. Drug Development and Industrial Pharmacy , 26, 1067-1076. https://doi.org/10.1081/ddc-100100270
Tantishaiyakul, V., Kaewnopparat, N. and Ingkatawornwong, S. (1996) Properties of Solid Dispersions of Piroxicam in Polyvinylpyrrolidone K-30. International Journal of Pharmaceutics , 143, 59-66. https://doi.org/10.1016/s0378-5173(96)04687-x
Wu, K., Li, J., Wang, W. and Winstead, D.A. (2009) Formation and Characterization of Solid Dispersions of Piroxicam and Polyvinylpyrrolidone Using Spray Drying and Precipitation with Compressed Antisolvent. Journal of Pharmaceutical Sciences , 98, 2422-2431. https://doi.org/10.1002/jps.21598
Liu, X., Michalchuk, A.A.L., Pulham, C.R. and Boldyreva, E.V. (2019) An Acetonitrile-Solvated Co-crystal of Piroxicam and Succinic Acid with Co-Existing Zwitterionic and Non-Ionized Piroxicam Molecules. Acta Crystallographica Section C Structural Chemistry , 75, 29-37. https://doi.org/10.1107/s2053229618016911
Liu, Y., Wu, T. and Wang, X. (2025) Machine Vision and Image Processing for Intelligent Online Monitoring and Control of Pharmaceutical Fluidized Bed Granulation Processes. Fourth International Conference on Computer Vision , Application , and Algorithm ( CVAA 2024), 13486, 134861H. https://doi.org/10.1117/12.3055987
Van Hauwermeiren, D., Stock, M., De Beer, T. and Nopens, I. (2020) Predicting Pharmaceutical Particle Size Distributions Using Kernel Mean Embedding. Pharmaceutics , 12, Article 271. https://doi.org/10.3390/pharmaceutics12030271
Lee, S.L., O’Connor, T.F., Yang, X., Cruz, C.N., Chatterjee, S., Madurawe, R.D., et al . (2015) Modernizing Pharmaceutical Manufacturing: From Batch to Continuous Production. Journal of Pharmaceutical Innovation , 10, 191-199. https://doi.org/10.1007/s12247-015-9215-8
Wilms, A., Teske, A., Meier, R., Wiedey, R. and Kleinebudde, P. (2022) Implementing Feedback Granule Size Control in a Continuous Dry Granulation Line Using Controlled Impeller Speed of the Granulation Unit, Compaction Force and Gap Width. Journal of Pharmaceutical Innovation , 17, 449-459. https://doi.org/10.1007/s12247-020-09524-3
Stock, S.R. (1999) X-Ray Microtomography of Materials. International Materials Reviews , 44, 141-164. https://doi.org/10.1179/095066099101528261
Norman, J., Madurawe, R.D., Moore, C.M.V., Khan, M.A. and Khairuzzaman, A. (2017) A New Chapter in Pharmaceutical Manufacturing: 3D-Printed Drug Products. Advanced Drug Delivery Reviews , 108, 39-50. https://doi.org/10.1016/j.addr.2016.03.001
U.S. Food and Drug Administration (2017) Advancement of Emerging Technology Applications for Pharmaceutical Innovation and Modernization Guidance for Industry. FDA.
Timoumi, A., Nguyen, T.C., Le, T., Kraiem, H., Cescut, J., Anne-Archard, D., et al . (2023) Comparison of Methods to Explore the Morphology and Granulometry of Biological Particles with Complex Shapes: Interpretation and Limitations. Powder Technology , 415, Article 118067. https://doi.org/10.1016/j.powtec.2022.118067